141 related articles for article (PubMed ID: 37129787)
1. Impact of Race and Ethnicity on Severe Hypoglycemia Associated with Sulfonylurea Use for Type 2 Diabetes among Veterans.
Weeda ER; Ward R; Gebregziabher M; Axon RN; Taber DJ
J Racial Ethn Health Disparities; 2024 Jun; 11(3):1427-1433. PubMed ID: 37129787
[TBL] [Abstract][Full Text] [Related]
2. Sulfonylureas as second line therapy for type 2 diabetes among veterans: Results from a National Longitudinal Cohort Study.
Weeda ER; Ward R; Gebregziabher M; Chandler O; Strychalski ML; Axon RN; Taber DJ
Prim Care Diabetes; 2023 Aug; 17(4):386-391. PubMed ID: 37121788
[TBL] [Abstract][Full Text] [Related]
3. Association Between Metformin Initiation and Incident Dementia Among African American and White Veterans Health Administration Patients.
Scherrer JF; Morley JE; Salas J; Floyd JS; Farr SA; Dublin S
Ann Fam Med; 2019 Jul; 17(4):352-362. PubMed ID: 31285213
[TBL] [Abstract][Full Text] [Related]
4. Sulfonylureas as Initial Treatment for Type 2 Diabetes and the Risk of Severe Hypoglycemia.
Yu O; Azoulay L; Yin H; Filion KB; Suissa S
Am J Med; 2018 Mar; 131(3):317.e11-317.e22. PubMed ID: 29032229
[TBL] [Abstract][Full Text] [Related]
5. Deintensification of Treatment With Sulfonylurea and Insulin After Severe Hypoglycemia Among Older Adults With Diabetes.
Alexopoulos AS; Kahkoska AR; Pate V; Bradley MC; Niznik J; Thorpe C; Stürmer T; Buse J
JAMA Netw Open; 2021 Nov; 4(11):e2132215. PubMed ID: 34726745
[TBL] [Abstract][Full Text] [Related]
6. Impact of diabetes control on mortality by race in a national cohort of veterans.
Hunt KJ; Gebregziabher M; Lynch CP; Echols C; Mauldin PD; Egede LE
Ann Epidemiol; 2013 Feb; 23(2):74-9. PubMed ID: 23238350
[TBL] [Abstract][Full Text] [Related]
7. Risk of hypoglycemia following intensification of metformin treatment with insulin versus sulfonylurea.
Roumie CL; Min JY; Greevy RA; Grijalva CG; Hung AM; Liu X; Elasy T; Griffin MR
CMAJ; 2016 Apr; 188(6):E104-E112. PubMed ID: 26811361
[TBL] [Abstract][Full Text] [Related]
8. Comparative Effectiveness of Insulin versus Combination Sulfonylurea and Insulin: a Cohort Study of Veterans with Type 2 Diabetes.
Min JY; Griffin MR; Hung AM; Grijalva CG; Greevy RA; Liu X; Elasy T; Roumie CL
J Gen Intern Med; 2016 Jun; 31(6):638-46. PubMed ID: 26921160
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal differences in glycemic control by race/ethnicity among veterans with type 2 diabetes.
Egede LE; Mueller M; Echols CL; Gebregziabher M
Med Care; 2010 Jun; 48(6):527-33. PubMed ID: 20473215
[TBL] [Abstract][Full Text] [Related]
10. Racial differences in trends of serious hypoglycemia among higher risk older adults in US Veterans Health Administration, 2004-2015: Relationship to comorbid conditions, insulin use, and hemoglobin A1c level.
Tseng CL; Aron DC; Soroka O; Lu SE; Myers CE; Pogach LM
J Diabetes Complications; 2020 Mar; 34(3):107475. PubMed ID: 31948777
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness of sulfonylurea and metformin monotherapy on cardiovascular events in type 2 diabetes mellitus: a cohort study.
Roumie CL; Hung AM; Greevy RA; Grijalva CG; Liu X; Murff HJ; Elasy TA; Griffin MR
Ann Intern Med; 2012 Nov; 157(9):601-10. PubMed ID: 23128859
[TBL] [Abstract][Full Text] [Related]
12. Differential impact of longitudinal medication non-adherence on mortality by race/ethnicity among veterans with diabetes.
Egede LE; Lynch CP; Gebregziabher M; Hunt KJ; Echols C; Gilbert GE; Mauldin PD
J Gen Intern Med; 2013 Feb; 28(2):208-15. PubMed ID: 22948932
[TBL] [Abstract][Full Text] [Related]
13. Metformin vs sulfonylurea use and risk of dementia in US veterans aged ≥65 years with diabetes.
Orkaby AR; Cho K; Cormack J; Gagnon DR; Driver JA
Neurology; 2017 Oct; 89(18):1877-1885. PubMed ID: 28954880
[TBL] [Abstract][Full Text] [Related]
14. Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort study.
Rentsch CT; Kidwai-Khan F; Tate JP; Park LS; King JT; Skanderson M; Hauser RG; Schultze A; Jarvis CI; Holodniy M; Lo Re V; Akgün KM; Crothers K; Taddei TH; Freiberg MS; Justice AC
PLoS Med; 2020 Sep; 17(9):e1003379. PubMed ID: 32960880
[TBL] [Abstract][Full Text] [Related]
15. Association of Race and Ethnicity With Prescription of SGLT2 Inhibitors and GLP1 Receptor Agonists Among Patients With Type 2 Diabetes in the Veterans Health Administration System.
Lamprea-Montealegre JA; Madden E; Tummalapalli SL; Peralta C; Neilands TB; Garcia PK; Muiru A; Karliner L; Shlipak MG; Estrella MM
JAMA; 2022 Sep; 328(9):861-871. PubMed ID: 36066519
[TBL] [Abstract][Full Text] [Related]
16. Comparative Safety of Sulfonylurea and Metformin Monotherapy on the Risk of Heart Failure: A Cohort Study.
Roumie CL; Min JY; D'Agostino McGowan L; Presley C; Grijalva CG; Hackstadt AJ; Hung AM; Greevy RA; Elasy T; Griffin MR
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28424149
[TBL] [Abstract][Full Text] [Related]
17. Effect of metformin-containing antidiabetic regimens on all-cause mortality in veterans with type 2 diabetes mellitus.
Gosmanova EO; Canada RB; Mangold TA; Rawls WN; Wall BM
Am J Med Sci; 2008 Sep; 336(3):241-7. PubMed ID: 18794619
[TBL] [Abstract][Full Text] [Related]
18. Mortality Associated with Metformin Versus Sulfonylurea Initiation: A Cohort Study of Veterans with Diabetes and Chronic Kidney Disease.
Marcum ZA; Forsberg CW; Moore KP; de Boer IH; Smith NL; Boyko EJ; Floyd JS
J Gen Intern Med; 2018 Feb; 33(2):155-165. PubMed ID: 29181788
[TBL] [Abstract][Full Text] [Related]
19. Race, ethnicity, and use of thiazolidinediones among US adults with diabetes.
Aquilante CL; Zhang W; McCollum M
Curr Med Res Opin; 2007 Mar; 23(3):489-94. PubMed ID: 17355730
[TBL] [Abstract][Full Text] [Related]
20. Hospitalization for Lactic Acidosis Among Patients With Reduced Kidney Function Treated With Metformin or Sulfonylureas.
Chu PY; Hackstadt AJ; Chipman J; Griffin MR; Hung AM; Greevy RA; Grijalva CG; Elasy T; Roumie CL
Diabetes Care; 2020 Jul; 43(7):1462-1470. PubMed ID: 32327421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
